(2S,3R)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-hydroxy-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]-1-pyrrolidin-1-ylpropan-1-one

It serves as a precursor to the final active ingredient by providing the necessary stereochemistry for the 2,3-dihydro-1,4-benzodioxin-6-yl side chain and the 2-amino-1-pyrrolidin-1-ylpropan-1-one structure. (2S,3R)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-hydroxy-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]-1-pyrrolidin-1-ylpropan-1-one is a key chiral intermediate in the synthesis of Eliglustat Tartrate, a medication for Type 1 Gaucher disease.

API Name Eliglustat tartrate
CAS No 491833-26-2
Molecular Formula C23H28N2O5
Molecular Weight 412.5 g/mol
Synonyms (2S,3R)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-hydroxy-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]-1-pyrrolidin-1-ylpropan-1-one

Frequently Asked Questions